Savient Pharmaceuticals, Inc.
has appointed Richard Crowley
as co-president and chief operating officer, John P. Hamill
, who will serve as co-president and chief financial officer, and Philip K. Yachmetz
, who will serve as co-president and chief business officer. Louis Ferrari
, president, chief executive officer, and director, is leaving the company to pursue other interests.
The board of directors thanks Mr. Ferrari for his valuable contributions throughout his tenure and wishes him well in his future endeavors.